Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity

Sponsor
University of Colorado, Denver (Other)
Overall Status
Recruiting
CT.gov ID
NCT05107908
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (NIH)
228
1
3
48.6
4.7

Study Details

Study Description

Brief Summary

The purpose of this study is to determine how different behavioral interventions designed to alter food perceptions and behaviors affect brain responses to food, eating behaviors, and body weight.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Active Implicit Priming
  • Behavioral: Control Implicit Priming
  • Behavioral: Food Exposure Task
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
228 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Other
Official Title:
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
Actual Study Start Date :
Nov 12, 2021
Anticipated Primary Completion Date :
Dec 1, 2025
Anticipated Study Completion Date :
Dec 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Active Implicit Priming

Participants will complete active implicit priming, in which food images are implicitly primed (i.e., below conscious awareness) with images of positive or negative affect. This will be completed on a weekly basis for 12 weeks, for approximately 10 minutes each time.

Behavioral: Active Implicit Priming
Approximately 10-minute behavioral intervention

Placebo Comparator: Control Implicit Priming

Participants will complete control implicit priming, which matches the active intervention, but with neutral stimuli as primes. This will be completed on a weekly basis for 12 weeks, for approximately 10 minutes each time.

Behavioral: Control Implicit Priming
Approximately 10-minute behavioral intervention

Active Comparator: Food Exposure Task

Participants will complete a Food Exposure Task, in which they will be asked to smell, feel, lick, and imagine eating food items, but without actually eating them. This will be completed on a weekly basis for 12 weeks, for approximately 10-30 minutes each time.

Behavioral: Food Exposure Task
Approximately 10-30 minute behavioral intervention

Outcome Measures

Primary Outcome Measures

  1. Percent Change in Blood Oxygen Level Dependent (BOLD) Response to Visual Food Cues as Measured by Functional Magnetic Resonance Imaging [Baseline, 12 weeks]

    Percent change in blood oxygen level dependent (BOLD) response from baseline to after the 12-week intervention while viewing visual food cues will be measured using functional magnetic resonance imaging (fMRI), focusing on insula, striatum, and prefrontal cortex.

  2. Change in Food Image Ratings [Baseline, 12 weeks]

    Food image ratings change from baseline to after the 12-week intervention. Food images are rated on "desire to eat" by visual analogue scale (0-100), with higher scores indicating greater desire to eat.

  3. Change in Food Intake [Baseline, 12 weeks]

    Food intake change from baseline to after the 12-week intervention. Food intake will be measured as total calories consumed during an ad libitum meal.

Secondary Outcome Measures

  1. Percent Change in Body Weight [Baseline, 12 weeks]

    Percent change in body weight (kg) from baseline to after the 12-week intervention.

  2. Change in Fat Mass [Baseline, 12 weeks]

    Change in fat mass, as measured using dual-energy x-ray absorptiometry, from baseline to after the 12-week intervention.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 18-65 years old

  • BMI of 27 or greater

Exclusion Criteria:
  • MRI contraindications (e.g., metal or electronic devices in the body)

  • Pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Colorado Anschutz Medical Campus Aurora Colorado United States 80045

Sponsors and Collaborators

  • University of Colorado, Denver
  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators

  • Principal Investigator: Jason Tregellas, PhD, University of Colorado, Denver

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Colorado, Denver
ClinicalTrials.gov Identifier:
NCT05107908
Other Study ID Numbers:
  • 20-2821
  • R01DK125417
First Posted:
Nov 4, 2021
Last Update Posted:
Nov 19, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of Colorado, Denver
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 19, 2021